Global Medical REIT Reports Q2 Net Loss Amid Acquisition Moves
Global Medical REIT reports $3.1M net loss for Q2 2024. Key highlights include acquisitions and high portfolio occupancy despite challenges.
- Latest
- Trending
Global Medical REIT reports $3.1M net loss for Q2 2024. Key highlights include acquisitions and high portfolio occupancy despite challenges.
Unpacking the recent stock market volatility and what it means for your investments. Learn how to navigate through the market's ...
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Inspire Medical Systems reports a 30% revenue increase in Q2 2024, with net income of $9.8 million, and raises full-year ...
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
A hospice center in Yuma introduces VR to offer mobility-limited patients therapeutic benefits and mental relief.
McLaren Health Care is experiencing IT and phone system outages, impacting patient services. The health system is working to resolve ...
DaVita increases 2024 profit outlook due to high demand for kidney dialysis services, boosting shares by 3% in aftermarket trade.
TG Therapeutics' Q2 2024 results show BRIUMVI sales at $72.6M, prompting a revenue guidance raise to $290-$300M.
Interlynk to provide SBOM generation, vulnerability reporting, and risk assessment for BIOTRONIK's life-saving products.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.